We exploited its high affinity for cathepsin D, thus employing it as a targeting moiety on the surfaces of liposomes, forming so-called immunoliposomes, and demonstrated its ability to bind to tumor cell surfaces, thus confirming its potential for theragnostic applications as a targeted drug delivery system. This evidence concerns the gene CTSD and neoplasm.